Genetic abnormalities and dysregulation of MYB have been found in several cancers, including adenoid cystic carcinoma (ACC) (80% of cases), making it an attractive druggable target for ACC treatment.

Salivary gland adenoid cystic carcinoma (SACC) is a rare cancer with low survival rates and frequent metastasis with currently no effective systemic treatment available, therefore representing an area ...